Non-Enzymatic Lipid Peroxidation in Cancer Biology: An Overview
Open Access
- 23 June 2026
- journal article
- review article
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 31 (6) , 47727
Abstract
Cancer is characterized by a disrupted redox balance and impaired antioxidant defense, leading to the excessive production of reactive oxygen species (ROS) and oxidative stress. While moderate levels of ROS support tumor growth and adaptation, excessive oxidative stress induces lipid peroxidation (LPO), a self-catalyzed chain reaction that destroys cell membranes and generates reactive aldehydes. Among such reactive aldehydes, 4-hydroxynonenal (HNE) is considered a second messenger of ROS, exerting concentration- and context-dependent effects on cell proliferation, differentiation, apoptosis, immune modulation, and cell death. Since cancer cells are typically more sensitive to the cytotoxicity of HNE, it may also be considered not only a cofactor in carcinogenesis but also a natural factor in the organism’s defense against cancer. This paper provides a comprehensive overview of non-enzymatic LPO in cancer, highlighting its dual role in tumor promotion and suppression. We discuss how persistent oxidative stress, metabolic reprogramming, and remodeling of the tumor lipidome shape LPO dynamics and ferroptosis susceptibility within the tumor microenvironment, as well as the emerging therapeutic strategies that exploit LPO. Therefore, exploring the advantage of LPO’s dualistic nature may help to develop more individualized and efficient integrative biomedicine anticancer treatments.Keywords
This publication has 134 references indexed in Scilit:
- Synergistic Ferroptosis–Immunotherapy Nanoplatforms: Multidimensional Engineering for Tumor Microenvironment Remodeling and Therapeutic OptimizationNano-Micro Letters, 2025
- Lipotoxicity, lipid peroxidation and ferroptosis: a dilemma in cancer therapyCell Biology and Toxicology, 2025
- A multifunctional nanoplatform for chemotherapy and nanocatalytic synergistic cancer therapy achieved by amplified lipid peroxidationActa Biomaterialia, 2024
- The expanding organelle lipidomes: current knowledge and challengesCellular and Molecular Life Sciences, 2023
- Biocompatible Polymer‐Modified Nanoplatform for Ferroptosis‐Enhanced Combination Cancer TherapyMacromolecular Bioscience, 2023
- Oxidative stress stimulates invasive potential in rat C6 and human U-87 MG glioblastoma cells via activation and cross-talk between PKM2, ENPP2 and APE1 enzymesMetabolic Brain Disease, 2018
- Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancerMedical Oncology, 2009
- 4‐Hydroxynonenal and cell cycleBioFactors, 2005
- 4-Hydroxynonenal induces apoptosis, NF-κB-activation and formation of 8-isoprostane in vascular smooth nmuscle cellsBasic Research in Cardiology, 2001
- Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydesFree Radical Biology and Medicine, 1991